logo
episode-header-image
Sep 2022
14m 8s

Podcast 298: COPD exacerbations — 7 days...

NEJM Group
About this episode

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […]

The post Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 first appeared on Clinical Conversations.
Up next
Aug 2022
Podcast 301: Monkeypox — what to look for, how to treat
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. This time, we look to New York for guidance on recognizing and treating monkeypox. Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the monkeypox thicket in a 17-minute chat. Included b ... Show More
17m 28s
Aug 2022
Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mariano Provencio about the survival outcomes from the NADIM II trial. In that trial, patie ... Show More
9m 32s
Aug 2022
Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation for the Study of Lung Cancer (IASLC). As part of the NEJM Group’s coverage of the ... Show More
14m 58s
Recommended Episodes
Feb 2024
Outpatient Antibiotic Stewardship
Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Kelsey L. Jensen, Pharm.D., R.Ph. Guest: Daniel Ilges, Pharm.D., R.Ph., BCIPD The appropriate use of antibiotics is important for a variety of reasons. It helps keep our patients safe, helps maintain antibiotic effectiveness in trea ... Show More
23m 2s
Oct 2021
CODA Long-Term Trial Results: Antibiotics versus Surgery for Appendicitis
The CODA trial is back – this time to shed light on long-term outcomes for antibiotics versus surgery for appendicitis! Dr. David Flum, lead investigator of the CODA trial, and Dr. Lillian Kao join us today to discuss the results after at least 1 year of follow-up in their patien ... Show More
25m 10s
Jun 2024
Antibiotikaresistenzen: Eine interdisziplinäre Herausforderung
Interview mit Dr. Miriam Stegemann, Antibiotic Stewardship Expertin und Oberärztin für Infektiologie am Virchow-Klinikum der Charité Antibiotikaresistenzen: Vom richtigen Umgang mit Antibiotika bis Therapien der Zukunft Inhaltsverzeichnis: 00:35 Intro 02:15 Resistenzentwicklung u ... Show More
32m 37s
May 2023
ASCO23: PALMIRA, LEONARDA-1, and Other Advances in Breast Cancer
Dr. Allison Zibelli and Dr. Megan Kruse highlight the PALMIRA and LEONARDA-1 trials, a new standard of care in the treatment of hand-foot syndrome for patients receiving capecitabine, and other key breast cancer studies that will be featured at the 2023 ASCO Annual Meeting. TRANS ... Show More
19m 49s
May 2024
Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors Rapid Update
Dr. Rachel Freedman and Dr. Sharon Giordano share the latest rapid guideline update from ASCO on the adjuvant use of the CDK4/6 inhibitors abemaciclib and ribociclib in patients with stage II and III breast cancer. They share details on the impetus for the update, supporting evid ... Show More
11m 23s
Feb 2024
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.3 Part 1
Dr. Jyoti Patel and Dr. Natasha Leighl discuss the latest full update to the stage IV NSCLC without driver alterations living guideline. This guideline addresses first-, second-, and subsequent-line therapy for patients according to their histology (squamous cell and nonsquamous ... Show More
9m 49s
May 2024
ASCO24: The Future of Personalized Immunotherapy
Dr. Diwakar Davar and Dr. Jason Luke discuss key abstracts from the 2024 ASCO Annual Meeting that explore triplet therapy in advanced melanoma, TIL cell therapy in immune checkpoint inhibitor–naive patients, and other novel approaches that could shape the future of immunotherapy ... Show More
34m 42s
Jun 2023
THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23
Drs. Rana McKay and Jonathan Rosenberg highlight key advances in genitourinary cancers featured at the 2023 ASCO Annual Meeting, including the THOR study in mUCC, VESPER in muscle-invasive bladder cancer, CONTACT-03 in mRCC, and TALAPRO-2 in mCRPC. TRANSCRIPT  Dr. Rana McKay: Hel ... Show More
23m 25s
Apr 2023
VTE Prophylaxis and Treatment in Patients with Cancer Guideline Update
Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for VTE treatment in patients with cancer and evaluating direct factor Xa inhibitors ... Show More
14m 5s
Sep 2021
Dr Andrew Weil on How To Reduce Inflammation and Create Health #200
I’m kicking off this season of the podcast with a very special guest. Dr Andrew Weil is a pioneer in the field of integrative health and is the founder and Director of the University of Arizona’s Center for Integrative Medicine – where he’s also Clinical Professor of Medicine and ... Show More
1h 52m